PAPER Dong M, Liu C, Luo H, Su D, Li G, Xu F, Song M, Zhang Y
SEARCH RESULTS
5492 RESULTS
PAPER Huang C, Qiu L, Zhou W, Shao C, Wang X, Zhang Q, Chen W, Xiong M, Huang M, Tang M, Zou L, Xu X
A human-induced pluripotent stem cell (iPSC) line (SMUSHi006-A) from an ALS patient carrying a mutation c.1126C > T in the FUS gene.
Stem Cell Res. 2025 Feb;82:103604. Epub 2024 Nov 9 PubMed.PAPER Aparajita A, Jain U, Srivastava P
"Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective".
Neuroscience. 2025 Jan 26;565:499-518. Epub 2024 Dec 9 PubMed.PAPER Keethedeth N, Anantha Shenoi R
Mitochondria-targeted nanotherapeutics: A new frontier in neurodegenerative disease treatment.
Mitochondrion. 2024 Dec 9;81:102000. Epub 2024 Dec 9 PubMed.PAPER Zhou T, Zu G, Zhang X, Wang X, Li S, Gong X, Liang Z, Zhao J
Corrigendum to "Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease" [Neuropharmacology 101 (2016) 480-489 NEUROPHARM-D-15-00626].
Neuropharmacology. 2025 Mar 1;265:110260. Epub 2024 Dec 9 PubMed. Corrected paper.PAPER Shoup D, Priola SA
Chaperone-mediated disaggregation of infectious prions releases particles that seed new prion formation in a strain-specific manner.
J Biol Chem. 2025 Jan;301(1):108062. Epub 2024 Dec 9 PubMed.PAPER Zhou XP, Sun LB, Liu WH, Zhu WM, Li LC, Song XY, Xing JP, Gao SH
The complex relationship between gut microbiota and Alzheimer's disease: A systematic review.
Ageing Res Rev. 2025 Feb;104:102637. Epub 2024 Dec 9 PubMed.PAPER Leclercq L, de Vries R, Koppen V, Verboven P, Cuyckens F, Wynant I, Vermeulen WA, Naisbitt D, Ford M, Meng X, Sakamoto S, Fukushima T, Snoeys J
CYP3A4-Mediated Bioactivation of the β-Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor JNJ-54861911 Results in Redox-Neutral Addition of Glutathione via Catalysis by Glutathione S-Transferase α1, Identified as the Major Target Protein in Human Hepat
Chem Res Toxicol. 2025 Jan 20;38(1):58-72. Epub 2024 Dec 11 PubMed.PAPER Houchois JR, Attwood JE
The Challenges of Modulating Neuroinflammation in Alzheimer's Disease and Multiple Sclerosis with TREM2 Agonistic Antibodies.
J Neurosci. 2024 Dec 11;44(50) PubMed.PAPER Nielsen TR, de Mendonça A, Frölich L, Engelborghs S, Gove D, Lamirel D, Calia C, Waldemar G
Assessment of Dementia in Minority Ethnic Groups in Europe: A 14-Year Follow-Up Survey.
Int J Geriatr Psychiatry. 2024 Dec;39(12):e70034. PubMed.PAPER Bhansali A, Sudheer D, Tiwari S, Desanamukula VS, Ahmad F
Prediction of Alzheimer's Disease Using Modified DNN with Optimal Feature Selection Based on Seagull Optimization.
J Imaging Inform Med. 2024 Dec 11; Epub 2024 Dec 11 PubMed.PAPER Mohan R, Arunachalam R, Verma N, Mali S
ViTBayesianNet: An adaptive deep bayesian network-aided alzheimer disease detection framework with vision transformer-based residual densenet for feature extraction using MRI images.
Network. 2024 Dec 11;:1-41. Epub 2024 Dec 11 PubMed.PAPER Suganya S, Ashok BS, Ajith TA
A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease.
Cell Biochem Funct. 2024 Dec;42(8):e70025. PubMed.PAPER Viljaharju V, Mertsalmi T, Pauls KA, Koivu M, Eerola-Rautio J, Udd M, Pekkonen E
Direct Initiation of Levodopa-Carbidopa Intestinal Gel Infusion After a Positive Levodopa Challenge Test in Advanced Parkinson's Disease.
Brain Behav. 2024 Dec;14(12):e70193. PubMed.PAPER An C, Cai H, Ren Z, Fu X, Quan S, Jia L
Biofluid biomarkers for Alzheimer's disease: past, present, and future.
Med Rev (2021). 2024 Dec;4(6):467-491. Epub 2024 Oct 17 PubMed.Current Filters
- Date Range : Past 90 Days x